Tag: Prescription Drugs
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Risks for MACE, MI, cardiovascular death, heart failure, all-cause mortality lower versus DPP-4 inhibitors
Metformin May Slow Cognitive Decline in Seniors With T2DM
Cognitive decline slower, dementia risk reduced in seniors with diabetes receiving metformin
PrEP Prescribing Low in the U.S., Even Among HIV Care Providers
About half of survey participants recruited from HIV CME courses reported ever prescribing PrEP
Avelumab Prolongs Survival in Advanced Urothelial Cancer
Findings seen in patients with advanced, metastatic disease that did not progress with first-line chemo
Drug May Reduce Need for Ventilators in COVID-19 Patients
85 percent of study population was Hispanic, Black, Native American, other ethnic or racial minorities
Spironolactone Not Tied to Breast Cancer Recurrence
Drug can be used for alopecia treatment in breast cancer survivors
New Drug Shows Promise in Preventing Severe COVID-19
Drug is monoclonal antibody, a man-made copy of antibody produced by a recovered COVID-19 patient
Antipsychotic Rx Still Common With Intellectual Disabilities
Also, sharp increase seen in antidepressant prescriptions in 2014 versus 2004
Levodopa Benefits Neovascular Age-Related Macular Degeneration
Levodopa is safe and well-tolerated, improves visual outcomes, and delays anti-VEGF treatment
